These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

527 related items for PubMed ID: 15364796

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Cardiovascular and renal outcome in subjects with K/DOQI stage 1-3 chronic kidney disease: the importance of urinary albumin excretion.
    Brantsma AH, Bakker SJ, Hillege HL, de Zeeuw D, de Jong PE, Gansevoort RT, PREVEND Study Group.
    Nephrol Dial Transplant; 2008 Dec; 23(12):3851-8. PubMed ID: 18641082
    [Abstract] [Full Text] [Related]

  • 24. C-reactive protein and prediction of coronary heart disease and global vascular events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER).
    Sattar N, Murray HM, McConnachie A, Blauw GJ, Bollen EL, Buckley BM, Cobbe SM, Ford I, Gaw A, Hyland M, Jukema JW, Kamper AM, Macfarlane PW, Murphy MB, Packard CJ, Perry IJ, Stott DJ, Sweeney BJ, Twomey C, Westendorp RG, Shepherd J, PROSPER Study Group.
    Circulation; 2007 Feb 27; 115(8):981-9. PubMed ID: 17283264
    [Abstract] [Full Text] [Related]

  • 25. Long-term follow-up of the West of Scotland Coronary Prevention Study.
    Ford I, Murray H, Packard CJ, Shepherd J, Macfarlane PW, Cobbe SM, West of Scotland Coronary Prevention Study Group.
    N Engl J Med; 2007 Oct 11; 357(15):1477-86. PubMed ID: 17928595
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Simvastatin for secondary prevention of all-cause mortality and major coronary events in patients with mild chronic renal insufficiency.
    Chonchol M, Cook T, Kjekshus J, Pedersen TR, Lindenfeld J.
    Am J Kidney Dis; 2007 Mar 11; 49(3):373-82. PubMed ID: 17336698
    [Abstract] [Full Text] [Related]

  • 28. Risk stratification according to the type of impaired renal function in patients with acute myocardial infarction treated with percutaneous coronary intervention.
    Kowalczyk J, Lenarczyk R, Kowalski O, Swiatkowski A, Stabryła-Deska J, Kurek T, Honisz G, Kukulski T, Gasior M, Kalarus Z.
    Kardiol Pol; 2007 Jun 11; 65(6):635-43; discussion 644. PubMed ID: 17629825
    [Abstract] [Full Text] [Related]

  • 29. Effects of anemia and left ventricular hypertrophy on cardiovascular disease in patients with chronic kidney disease.
    Weiner DE, Tighiouart H, Vlagopoulos PT, Griffith JL, Salem DN, Levey AS, Sarnak MJ.
    J Am Soc Nephrol; 2005 Jun 11; 16(6):1803-10. PubMed ID: 15857925
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR, Gandhi S, Blasetto J, Heien H, Sasane R, Nelson SP.
    Am J Geriatr Pharmacother; 2007 Sep 11; 5(3):185-94. PubMed ID: 17996658
    [Abstract] [Full Text] [Related]

  • 34. The pravastatin inflammation CRP evaluation (PRINCE): rationale and design.
    Albert MA, Staggers J, Chew P, Ridker PM, PRINCE Investigators.
    Am Heart J; 2001 Jun 11; 141(6):893-8. PubMed ID: 11376301
    [Abstract] [Full Text] [Related]

  • 35. Chronic kidney disease and dipstick proteinuria are risk factors for stent thrombosis in patients with myocardial infarction.
    Lambert ND, Sacrinty MT, Ketch TR, Turner SJ, Santos RM, Daniel KR, Applegate RJ, Kutcher MA, Sane DC.
    Am Heart J; 2009 Apr 11; 157(4):688-94. PubMed ID: 19332197
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Effect of gemfibrozil on change in renal function in men with moderate chronic renal insufficiency and coronary disease.
    Tonelli M, Collins D, Robins S, Bloomfield H, Curhan GC.
    Am J Kidney Dis; 2004 Nov 11; 44(5):832-9. PubMed ID: 15492949
    [Abstract] [Full Text] [Related]

  • 38. Rosuvastatin for cardiovascular prevention: too many uncertainties.
    Prescrire Int; 2009 Aug 11; 18(102):176. PubMed ID: 19746571
    [Abstract] [Full Text] [Related]

  • 39. [Does statin therapy reduce the risk of stroke? A meta-analysis].
    Sirol M, Bouzamondo A, Sanchez P, Lechat P.
    Ann Med Interne (Paris); 2001 Apr 11; 152(3):188-93. PubMed ID: 11431579
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.